Guidelines for clinical trials of new therapeutic agents in multiple sclerosis: Reporting extended results from phase III clinical trials

Authors:
  • NSNational Multiple Sclerosis Society Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis
    National Multiple Sclerosis Society Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis

Abstract
No abstract available